Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2001.233 | A Randomized, Multi-centre, Double-blind, Double-dummy, Parallel Group Trial of Two Doses of NNC 61-0029 in Combination with Glibenclamide Versus Glibenclamide Monotherapy and Versus Combination Therapy of Glibenclamide and Metformin in the Treatment of Subjects with Type 2 Diabetes | Dr. Chow C.C. Francis |
| 2001.205 | Biweekly Irinotecan(CPT-11), 5 Fluorouracil (5FU) and Folinic Acid (FA) in Unresectable Liver Metastastes from Colorectal Cancer: A Phase II Study | Prof. Chan T.C. Anthony |
| 2001.201 | A Study on Genetic Expressions during Ocular Development in Human Molecular Embryogenesis | Prof. PANG Chi Pui |
| 2001.199 | Comparison of a Clinical Pharmacist-managed Anticoagulation Service with Routine Medical Care - Impact on Clinical Outcomes and Healthcare Costs | YOU Hoi Sze Joyce |
| 2001.115 | Proton Pump Inhibitor for Uninvestigated H.Pylori-negative Dyspeptic Patients | Prof. Leung Wai Keung |
| 2001.053 | Randomised controlled trial of Levo-norgestrel intrauterine system in women receiving tamoxifen for carcinoma of breast | Dr. Chan Shing Chee Symphorosa |
| 2001.007 | Cyclooxygenase-2 in Human Gastric Ulcers: Biological and Clinical Perspectives | CHAN Ka Leung Francis |
| 2000.447 | Pre and Post-Operative Chemotherapy with Oxaliplatin 5FU/LV Versus Surgery Alone in Resectable Liver Metastases from Colorectal Origin Phase III Randomized Study | Prof. CHAN Anthony T.C. |
| 2000.428 | Should Intracytoplasmic Sperm Injection be the Method of Choice for Insemination in Patients with Poor Oocyte Quality or Unexplained Infertility Undergoing In-Vitro Fertilization Treatment-A Randomised and Controlled Trial on Sibling Oocytes | Dr. CHUNG Hoi Sze |
| 2000.422 | A Multicentre, Randomized, Double-blind, Controlled Study of Two Corticosteroid Regimens for Treatment of Systemic Hypotension in Preterm Infants | Prof. Ng Pak Cheung |
| 1995.526 | Randomized Trial of High-Dose Epirubicin and Cyclophamide x 3 Supported by Peripheral Blood Projector Cells Versus Anthracycline and Cyclophosphamide x 4 Followed by Cyclophosphamide, Methotrexate & 5- Fluorouracil as Adjuvant Treatment for High Risk Operable Stage II and Stage III Breast Cancer in Premenopausal and Young Postmenopausal (<65 yrs) Patients | Prof. YEO Winnie |
Page 254 of 254.